A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2011
10/12/2011	CN101642537B Cough-relieving traditional Chinese medicine
10/12/2011	CN101637546B Medicine for treating acute and chronic rhinitis and sinusitis
10/12/2011	CN101421252B 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists
10/12/2011	CN101306145B Traditional Chinese medicine orally taken for treating chronic nasal sinusitis
10/12/2011	CN101204453B Tincture medicine for perennial allergic rhinitis
10/12/2011	CN101116733B Medicinal pill for clearing away lung heat and treating pulmonary tuberculosis
10/11/2011	US8034958 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
10/11/2011	US8034933 graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis; human immunodeficiency viricides
10/11/2011	US8034826 Cycloalkane[B]azaindole antagonists of prostaglandin D2 receptors
10/11/2011	US8034810 Matrix metalloproteinase inhibitors; antiinflammatory agengs; rheumatoid arthritis, osteoarthritis; antitumor, anticarcinogenic, and antimetastasis agents; respiratory system disorders, chronic obstructive pulmonary disease, deblocking, deprotecting
10/11/2011	US8034809 Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
10/11/2011	CA2494100C Pyrazole compositions useful as inhibitors of gsk-3
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/11/2011	CA2483620C Compositions for preventing or treating pollenosis, allergic nephritis, atopic dermatitis, asthma or urticaria
10/11/2011	CA2476405C Compositions and methods for treatment of microbial infections
10/11/2011	CA2472479C Deazapurines and uses thereof
10/11/2011	CA2457027C Chitin microparticles and their medical uses
10/11/2011	CA2394862C Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder
10/06/2011	WO2011123179A2 Alkylated sp-c peptoid compounds and related surfactant compositions
10/06/2011	WO2011122619A1 Phenylalanine derivative salt crystal
10/06/2011	WO2011121425A1 Pharmaceutical powder composition for inhalation
10/06/2011	WO2011121366A1 Pyrazole p38 map kinase inhibitors
10/06/2011	WO2011120604A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion"
10/06/2011	WO2011120339A1 Microemulsion formulation containing arctigenin
10/06/2011	WO2010103279A8 Bis aromatic compounds for use as ltc4 synthase inhibitors
10/06/2011	US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011	US20110245325 Pharmaceutical composition for treatment of cancer and asthma
10/06/2011	US20110245323 RIG-Like Helicase Innate Immunity Inhibits VEGF-Induced Tissue Responses
10/06/2011	US20110245322 Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of cf-associated mutant cystic fibrosis transmembrane conductance regulator
10/06/2011	US20110245310 Novel Compounds
10/06/2011	US20110245303 Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
10/06/2011	US20110245297 Use Quaternary Pyridinium Salts as Vasoprotective Agents
10/06/2011	US20110245293 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist
10/06/2011	US20110245292 2-hydroxy-ethanesulfonate salt
10/06/2011	US20110245291 Tricyclic delta-opioid modulators
10/06/2011	US20110245271 Triazole-substituted arylamides as p2x3 and p2x2/3 antagonists
10/06/2011	US20110245270 Nicotinic receptor agonists for the treatment of inflammatory diseases
10/06/2011	US20110245267 Piperidine and piperazine derivatives and methods of use thereof
10/06/2011	US20110245253 Method for treating a pulmonary hypertension condition
10/06/2011	US20110245251 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/06/2011	US20110245248 Isoquinoline derivatives
10/06/2011	US20110245245 Methods of treatment comprising the administration of heteroaryl compounds
10/06/2011	US20110245238 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof
10/06/2011	US20110245230 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
10/06/2011	US20110245225 Quinazolinamide derivatives
10/06/2011	US20110245222 Methods for Using Carboxamide, Sulfonamide and Amine Compounds
10/06/2011	US20110245217 Methods for diagnosing and treating asthma
10/06/2011	US20110245214 Organic compounds
10/06/2011	US20110245209 Pyridopyrimidine derivatives and methods of use thereof
10/06/2011	US20110245205 Aminopyrimidines as syk inhibitors
10/06/2011	US20110245202 Pharmaceutical composition for the treatment of rhinitis
10/06/2011	US20110245197 Hypersulfated glucopyranosides
10/06/2011	US20110245192 New activators for treating and/or preventing diseases or medical conditions which benefit from an increased transport of hyaluronan across a lipid bilayer
10/06/2011	US20110244064 composition for the treatment of hypertension
10/06/2011	US20110244059 Inhibiting obesity progression by inhibiting adipocyte differentiation with a pre-adipocyte autophagy inhibitor
10/06/2011	US20110244058 Compositions and methods for treatment of pulmonary diseases and conditions
10/06/2011	US20110244053 Use a goat serum for veterinary treatment
10/06/2011	US20110244025 Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
10/06/2011	US20110244002 Mesoporous material excipients for poorly aqueous soluble ingredients
10/06/2011	US20110243999 Methods and compositions for the treatment of ocular disorders
10/06/2011	US20110243997 Film-form preparation and method for producing the same
10/06/2011	US20110243992 Methods of enhancing the immunogenicity of mycobacteria and compositions for the treatment of cancer, tuberculosis, and fibrosing lung diseases
10/06/2011	US20110243953 Neutralizing antibodies against gdf-8 and uses therefor
10/06/2011	US20110243951 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins
10/06/2011	US20110243943 Treatment using relaxin-fusion proteins with extended in vivo half-lives
10/06/2011	US20110243940 Bicyclic pyranone derivatives and methods of use thereof
10/06/2011	US20110243936 TNFalpha-NEUTRALIZING ANTIBODIES
10/06/2011	US20110243930 Compositions and methods for the treatment of immune related diseases
10/06/2011	US20110243928 Chimeric and humanised monoclonal antibodies against interleukin-13
10/06/2011	US20110243926 Anti-p-selectin antibodies and methods of using the same to treat inflammatory diseases
10/06/2011	US20110243924 Novel methods
10/06/2011	US20110243923 Organic compounds
10/06/2011	US20110243911 Use of a compound capable of reducing the uric acid level for the prevention and/or the treatment of lung inflammation and fibrosis
10/06/2011	US20110243910 mammalian rna dependent rna polymerase
10/06/2011	US20110243890 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus
10/06/2011	US20110243889 Opioid and opioid-like compounds and uses thereof
10/06/2011	US20110240012 Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis
10/06/2011	CA2795043A1 Humanized il-25 antibodies
10/06/2011	CA2794773A1 Trpv1 vanilloid receptor antagonists with a bicyclic portion
10/06/2011	CA2794308A1 Hypersulfated glucopyranosides
10/05/2011	EP2371861A1 Monoclonal antibodies against extracellular loops of C5aR
10/05/2011	EP2371820A1 Optically active cyclic alcohol compound and method for preparing the same
10/05/2011	EP2371393A1 Preventive or remedy for inflammatory disease
10/05/2011	EP2371366A1 Heterocyclo inhibitors of potassium channel function
10/05/2011	EP2370429A1 P38 map kinase inhibitors
10/05/2011	EP2370428A1 P38 map kinase inhibitors
10/05/2011	EP2370413A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
10/05/2011	EP2370068A2 Methods and compositions for delivery of medicaments to the lungs
10/05/2011	EP2083920B1 N-aryl-hydroxyalkylidene-carboxamide compounds and their use
10/05/2011	EP1890994B1 Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
10/05/2011	EP1838329B1 Method for providing oral killed vaccines
10/05/2011	EP1708717B1 Atomoxetine for treatment of allergic rhinitis and asthma
10/05/2011	EP1651224B1 Medicaments for inhalation comprising an anticholinergic and a betamimetic
10/05/2011	EP1463497B1 Treating muscle wasting with selective androgen receptor modulators
10/05/2011	EP1377276B1 Timed pulse release composition
10/05/2011	EP1267945B1 Genetically modified cells expressing a tgf-beta inhibitor, the cells being lung cancer cells
10/05/2011	CN1817883B New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
10/05/2011	CN102209543A Pirfenidone treatment for patients with atypical liver function
10/05/2011	CN102206281A Fusion protein TETPH, expression vector and construction method thereof
10/05/2011	CN102206277A Antibodies that bind human interleukin-18 and methods of making and using

1 ... 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 ... 878